Swiss Pharm Co Wins FDA Approval To Start Hydroxychloroquine Clinical Trials In U.S.

Swiss pharmaceutical company Novartis has won approval from the U.S. Food and Drug Administration to begin a clinical trial on the efficacy of hydroxychloroquine in treating hospitalized COVID-19 patients. The trial will begin immediately in more than a dozen sites across the U.S. and will include about 440 patients. “We recognize the importance of answering … Continue reading Swiss Pharm Co Wins FDA Approval To Start Hydroxychloroquine Clinical Trials In U.S.